Ensemble Health Partners, which provides a healthcare revenue cycle management platform, withdrew its plans for an initial public offering on Friday. It had filed to raise $605 million by offering 29.5 million shares at a price range of $19 to $22, but postponed ahead of pricing in October.
The Cincinnati, OH-based company was founded in 2014 and booked $742 million in revenue for the 12 months ended June 30, 2021. It had planned to list on the Nasdaq under the symbol ENSB. Goldman Sachs, BofA Securities, Deutsche Bank, Guggenheim Securities, Credit Suisse, Evercore ISI, Wells Fargo Securities, SVB Leerink, Baird, and William Blair were set to be the joint bookrunners on the deal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.